News & Events
Does Good Cholesterol Increase Breast Cancer Risk?
A protein receptor for the "good cholesterol," HDL, may help make breast cancer more aggressive and offer a new target for treating the disease.
International Leaders in Diabetes Prevention, Treatment and Research Present at Jefferson Symposium: New Advances and Innovations
Second Annual Symposium includes keynote on management for obesity.
Health Insurance Exchanges: What We Can Learn from California
Thomas Jefferson University and URAC are releasing a study that examines the role of new types of health insurance created by the Affordable Care Act (A.C.A). Starting today, under...
Jefferson Researchers Receive Department of Defense Grant to Ease Recovery for Military Personnel with Orthopaedic Injuries Sustained in Combat or Combat-related Duties
Researchers with Jefferson Orthopedics are using their experience and expertise in post-traumatic joint stiffness to develop treatments that could aid in optimal recovery and...
JSN Celebrates Faculty Publications
Faculty and Staff Run up the Philadelphia Museum of Art steps.
Acid Accumulation in Breast Cancer Disables Powerful Protective Hormone
Runners often say their legs have gone sour because of the build-up of lactic acid in their muscles. Some breast tumors also produce lactic acid — and that makes them...
Radiotherapy for Prostate Cancer has Evolved but Questions of Long-term Benefit of Newer Technologies Remain
In a review of the state of prostate cancer radiotherapy, researchers conclude that the menu of options available for men is expanding. However, given the lack of evidence proving...
Promising Prostate Cancer Treatment Should Be Considered Experimental
Despite the growing desire by radiation oncologist to use high-dose brachytherapy alone to treat prostate cancer, the treatment should be considered experimental at this point, say...
A Link between Hormones and DNA Repair Provide New Clues to Treat Advanced Prostate Cancer
For advanced prostate cancers, new strategies for therapeutic intervention are urgently needed, and require a better understanding of how tumor cells go from slow growth to aggressive...
A Small Molecule Inhibitor of Jak2-Stat5 Signaling Pathway Stops Growth of Primary as well as Aggressive, Advanced Prostate Cancer
An experimental drug targeting Jak2-Stat5 signaling blocks growth of both primary prostate cancer and prostate cancer that has become castrate-resistant, a state in which the cancer is...